{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T20:50:44Z","timestamp":1693342244524},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.oftal.2013.10.007","type":"journal-article","created":{"date-parts":[[2014,10,25]],"date-time":"2014-10-25T04:17:42Z","timestamp":1414210662000},"page":"14-21","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Resultados coste-efectividad del implante de dexametasona en edema macular"],"prefix":"10.1016","volume":"90","author":[{"given":"V.","family":"Lozano L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Serrano Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mantol\u00e1n Sarmiento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Pareja R\u00edos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.J.","family":"Losada Castillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Cordov\u00e9s Dorta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Quijada Fumero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Virg\u00f3s Aller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bullejos Molina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oftal.2013.10.007_bib0005","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0161-6420(96)30653-2","article-title":"Prognostic factors for retinal vein occlusion: prospective study of 175 cases","volume":"103","author":"Glacet-Bernard","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftal.2013.10.007_bib0010","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1167\/iovs.10-5285","article-title":"Pharmacokinetics and pharmacodynamics of a sustained-release dexamethasone intravitreal implant","volume":"52","author":"Chang-Lin","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.oftal.2013.10.007_bib0015","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","article-title":"Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion","volume":"117","author":"Haller","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftal.2013.10.007_bib0020","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oftal.2013.10.007_bib0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4103\/0301-4738.95884","article-title":"Change in macular thickness in a case of refractory diabetic macular edema with dexamethasone intravitreal implant in comparison to intravitreal bevacizumab: A case report","volume":"60","author":"Sharma","year":"2012","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.oftal.2013.10.007_bib0030","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.ophtha.2010.12.034","article-title":"Economic considerations of macular edema therapies","volume":"118","author":"Smiddy","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftal.2013.10.007_bib0035","doi-asserted-by":"crossref","first-page":"789","DOI":"10.5301\/EJO.2011.6522","article-title":"Intravitreal bevacizumab in central retinal vein occlusion: 18-month results of a prospective clinical trial","volume":"21","author":"Algvere","year":"2011","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.oftal.2013.10.007_bib0040","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1016\/j.ophtha.2011.02.038","article-title":"Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study","volume":"118","author":"Campochiaro","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftal.2013.10.007_bib0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s00417-008-0980-7","article-title":"Physiology of vitreous surgery","volume":"247","author":"Stefansson","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oftal.2013.10.007_bib0050","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.ophtha.2011.05.014","article-title":"Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion. Twelve-month study results","volume":"118","author":"Haller","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/j.oftal.2013.10.007_bib0055","article-title":"Evidence review: Dexamethasone implants (Ozurdex\u00ae) for macular oedema after retinal vein occlusion","volume":"12","author":"Shyangdan","year":"2011","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.oftal.2013.10.007_bib0060","doi-asserted-by":"crossref","DOI":"10.3310\/hta12160","article-title":"Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: A systematic review and economic evaluation","volume":"12","author":"Colquitt","year":"2008","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.oftal.2013.10.007_bib0065","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/IAE.0b013e318206d18c","volume":"31","author":"Boyer","year":"2011","journal-title":"Retina"},{"key":"10.1016\/j.oftal.2013.10.007_bib0070","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0014-2999(97)01464-7","article-title":"Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells","volume":"341","author":"Nauck","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.oftal.2013.10.007_bib0075","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/archopht.125.3.309","article-title":"Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema","volume":"125","author":"Kuppermann","year":"2007","journal-title":"Arch Ophthalmol"}],"container-title":["Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669113003742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365669113003742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T07:28:09Z","timestamp":1538119689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365669113003742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0365669113003742"],"URL":"https:\/\/doi.org\/10.1016\/j.oftal.2013.10.007","relation":{},"ISSN":["0365-6691"],"issn-type":[{"value":"0365-6691","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resultados coste-efectividad del implante de dexametasona en edema macular","name":"articletitle","label":"Article Title"},{"value":"Archivos de la Sociedad Espa\u00f1ola de Oftalmolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oftal.2013.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Sociedad Espa\u00f1ola de Oftalmolog\u00eda. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}